To discover new medicines, #scientists analyze vast and often disparate data to find the proverbial needle in a haystack. See how our scientists are leveraging #AI and data tools to help gain insights in minutes: https://bit.ly/3zCaW1I [Video description: On-screen text reads, “The human body generates massive amounts of data, which scientists rely on to help understand the root causes of diseases. But scientists alone would need a lifetime to analyze all this data. Instead they’re using AI and an industry-leading data platform to collate over 2 billion points of knowledge to deliver insights that can help us discover new medicines faster.”]
Perihal kami
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Laman web
-
http://www.abbvie.com
Pautan luaran untuk AbbVie
- Industri
- Pembuatan Farmaseutikal
- Saiz syarikat
- 10,001+ pekerja
- Ibu pejabat
- North Chicago, Illinois
- Jenis
- Syarikat Awam
- Pengkhususan
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, Eye Care
Lokasi
Pekerja di AbbVie
Kemas Kini
-
NEWS: Today we announced positive topline results from our pivotal Phase 3 trial for our investigational treatment in #ParkinsonsDisease. Learn more about the results: https://bit.ly/3BkCfht [Video description: On-screen text reads, “Neuroscience News."]
-
#LiverCancer is the sixth most common cancer worldwide, and approximately 20% of liver cancer diagnoses are caused by #HepatitisC. Learn more about #HCV’s global impact and how we can act now to help eliminate the disease by 2030 in POLITICO Studio: https://politi.co/3ZJRAlI [Video description: Interview with John Ward, Director, Global Coalition for Hepatitis Elimination. On-screen text reads, “More than 800,000 people worldwide are diagnosed with liver cancer each year. We estimate that by 2030, if we achieve hepatitis C elimination goals, we can avert over two million deaths from liver disease, including liver cancer. Join us as we work to help eliminate Hepatitis C.”]
-
Through #migraine research, we’re dedicated to growing a deep understanding of the mental, physical and socio-economic impacts of this disease on patients. During #MigraineAwarenessWeek, learn more about the burden of migraine from our own employees: https://bit.ly/4gBOMgK [Video description: AbbVie employees share their experiences living with migraine. On-screen text reads, “Some AbbVie employees are migraine patients too.”]
-
NEWS: New post-hoc data of #atopicdermatitis stratified by the severity of disease in the head and neck region was presented today at the #EADVCongress. Learn more about how we’re striving to meet patient needs through new research and data in immune-mediated skin diseases: https://bit.ly/47Cf6mR [Video description: On-screen text reads, “Immunology News.”]
-
AbbVie in Australia is proud to support the Crohn’s & Colitis Australia Live Fearless Challenge for the sixth consecutive year. Fundraising efforts support CCA’s work in education, advocacy and research with the aim of improving outcomes for people affected by inflammatory bowel disease. Learn more about the month-long fitness challenge here: https://bit.ly/4ewOfL4. Crohn’s & Colitis Australia #livefearlesschallenge #IBD #community
-
-
#DrugDiscovery is like a puzzle - and our #MachineLearning team, led by Abhishek Pandey, is finding new ways to solve it. Watch the full conversation in Piecing It Together, a series featuring employees across our organization and how they’re solving challenges and making an impact: https://bit.ly/3XYWIS4 #AI [Video description: Two AbbVie employees sitting at a table, playing a game involving stacking blocks, while discussing machine learning in drug discovery.]
-
Tune into this year’s #EADVCongress to see how we’re striving to meet patient needs through new research and data in immune-mediated skin diseases: https://bit.ly/3zksYpf [Video description: Animation of people, a person speaking at a podium, and Amsterdam on a map. On-screen text reads, “EADV 2024 Looking ahead. 33 accepted abstracts across 5 immune-mediated skin diseases, atopic dermatitis, psoriasis, psoriatic arthritis, vitiligo, hidradenitis suppurativa, 6 oral presentations, 3 symposia. See you there!”]
-
Healthcare providers and caregivers are both pivotal members of the support team for patients living with #CLL. When all parties partner together to discuss the physical, mental and emotional effects of the disease, pathways are created for ensuring optimal care. Watch for a global report on insights for holistic care later this year. #BloodCancerAwarenessMonth [Image description: On-screen text reads, “Open communication between patients, caregivers and healthcare providers is critical to ensure the most optimal support. Join us to better the experience of those affected by CLL by encouraging shared decision-making. Coming soon: a global report to support the CLL community in their unique journeys.”]
-
#Migraine impacts more than just a patient’s life. A survey from EMHA- European Migraine and Headache Alliance shows that the neurological disease can also impact the European economy. Read the results here: https://bit.ly/4djkX1o #MigraineAwarenessWeek [Video description: On-screen text reads, “The Hidden Cost of Migraine. How much did migraine alone impact the European Economy through the loss of productivity at work and work days lost? €27 Billion is Lost Annually in reduced productivity and lost workdays in the European Economy due to migraine alone.”]
Laman rakan sekutu
Laman yang serupa
Pendanaan
AbbVie
Jumlah 2 pusing
Lihat maklumat lanjut di crunchbase
Pusingan Terakhir
Hutang pasca IPO
Pautan Crunchbase Luaran untuk pusingan pendanaan terakhir
USD 15,000,000,000.00